United States · FDA National Drug Code directory
Cyclobenzaprine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-839_3b4cbe13-2679-7313-e063-6294a90a97ae
- Product NDC
- 76420-839
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200706
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE (76420-839-00) · 76420-839-00
- 1 TABLET, FILM COATED in 1 BOTTLE (76420-839-01) · 76420-839-01
- 2 TABLET, FILM COATED in 1 BOTTLE (76420-839-02) · 76420-839-02
- 500 TABLET, FILM COATED in 1 BOTTLE (76420-839-05) · 76420-839-05
- 7 TABLET, FILM COATED in 1 BOTTLE (76420-839-07) · 76420-839-07
- 100 TABLET, FILM COATED in 1 BOTTLE (76420-839-10) · 76420-839-10
- 20 TABLET, FILM COATED in 1 BOTTLE (76420-839-20) · 76420-839-20
- 30 TABLET, FILM COATED in 1 BOTTLE (76420-839-30) · 76420-839-30
- 60 TABLET, FILM COATED in 1 BOTTLE (76420-839-60) · 76420-839-60
- 90 TABLET, FILM COATED in 1 BOTTLE (76420-839-90) · 76420-839-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →